Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Double-Blind, Cross-Over Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02911597

Organisation Name: Stanford University

Overal Status: Completed

Start Date: September 2016

Last Update: April 24, 2018

Lead Sponsor: Stanford University

Brief Summary: The primary objective is to determine if the opioid properties of ketamine are responsible for its antidepressant effects. Since naltrexone can block opiate actions, the investigators will determine if naltrexone can effectively block ketamine's effects.

Conditions:
  • Depression


Total execution time in seconds: 0.14942789077759